Current approaches to the management of smoking cessation.
Smoking remains a widespread intractable behaviour and is a significant cause of morbidity and mortality worldwide. Effective approaches to smoking cessation include behavioural intervention and pharmacotherapy, in particular nicotine replacement therapy (NRT) and sustained-release bupropion (bupropion SR). Pharmacotherapy remains a popular choice of smoking cessation intervention for many smokers, and both NRT and bupropion SR, combined with behavioural interventions, achieve 1.5- to >2-fold increases in smoking cessation rates. Various national and international smoking cessation guidelines have been published recommending effective implementation of smoking cessation strategies. Recommendations include the systematic identification of smokers, assessment of their willingness to quit smoking, provision of advice promoting a cessation attempt, and administration of approved first-line therapies.
Sutherland
Gay
G
Tobacco Research Unit, Institute of Psychiatry, National Addiction Centre, Kings College, 4 Windsor Walk, London SE5 8AF, UK. g.sutherland@iop.kcl.ac.uk
D016642:Bupropion / Q000008:administration & dosage / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D015277:Hotlines; D006801:Humans; D009538:Nicotine / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011615:Psychotherapy, Group; D016540:Smoking Cessation / Q000379:methods*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D014029:Tobacco Use Disorder / Q000628:therapy*
D003692:Delayed-Action Preparations; D016642:Bupropion; D009538:Nicotine